De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment

被引：1
|
作者：
Fotiou, Despina [1 ]
Skalioti, Chrysanthi [2 ]
Liapis, George [3 ]
Marinaki, Smaragdi [2 ]
Kastritis, Efstathios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Laiko Hosp, Sch Med, Clin Nephrol & Renal Transplantat, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Laiko Hosp, Sch Med, Dept Pathol, Athens, Greece
来源：
HEMASPHERE | 2021年 / 5卷 / 12期
关键词：
DARATUMUMAB;
D O I：
10.1097/HS9.0000000000000665
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Anti CD38 monoclonal antibodies for multiple myeloma treatment
    Gozzetti, Alessandro
    Ciofini, Sara
    Simoncelli, Martina
    Santoni, Adele
    Pacelli, Paola
    Raspadori, Donatella
    Bocchia, Monica
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [32] Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
    Mayer, Katharina A.
    Budde, Klemens
    Halloran, Philip F.
    Doberer, Konstantin
    Rostaing, Lionel
    Eskandary, Farsad
    Christamentl, Anna
    Wahrmann, Markus
    Regele, Heinz
    Schranz, Sabine
    Ely, Sarah
    Firbas, Christa
    Schoergenhofer, Christian
    Kainz, Alexander
    Loupy, Alexandre
    Haertle, Stefan
    Boxhammer, Rainer
    Jilma, Bernd
    Boehmig, Georg A.
    TRIALS, 2022, 23 (01)
  • [33] Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature
    Barbieri, Emiliano
    Martino, Enrica Antonia
    Rivolti, Elena
    Quaresima, Micol
    Vigna, Ernesto
    Neri, Antonino
    Morabito, Fortunato
    Gentile, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (05) : 365 - 381
  • [34] Cumulative Incidence and Relative Risk of Infection in Patients With Multiple Myeloma Treated With Anti-CD38 Monoclonal Antibody-Based Regimens: A Systematic Review and Meta-analysis
    Vassilopoulos, Stephanos
    Vassilopoulos, Athanasios
    Kalligeros, Markos
    Shehadeh, Fadi
    Mylonakis, Eleftherios
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (11):
  • [35] Risk of new alloimmunization in patients on anti-CD38 treatment using tube LISS-IAT method
    Stanic, Hana Safic
    Galic, Zrinka Kruhonja
    Lukic, Martina
    Bingulac-Popovic, Jasna
    Jukic, Irena
    TRANSFUSION AND APHERESIS SCIENCE, 2024, 63 (02)
  • [36] Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series
    Chiu, Chia-Yu
    Mustafayev, Khalis
    Lee, Hans C.
    Manasanch, Elisabet E.
    Guevara, Eduardo Yepez
    Torres, Harrys A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (04) : 900 - 903
  • [37] A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies
    Zabaleta, Aintzane
    Blanco, Laura
    Kim, Peter S.
    Bisht, Kamlesh
    Wang, Hongfang
    Van de Velde, Helgi
    Lasa, Marta
    Tamariz-Amador, Luis-Esteban
    Rodriguez-Otero, Paula
    San-Miguel, Jesus
    Paiva, Bruno
    Martin-Sanchez, Esperanza
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2262 - 2267
  • [38] Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials
    de Moraes, Francisco Cezar Aquino
    Sano, Vitor Kendi Tsuchiya
    Lobo, Artur de Oliveira Macena
    Kelly, Francinny Alves
    Morbach, Victoria
    Pasqualotto, Eric
    Burbano, Rommel Mario Rodriguez
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (04):
  • [39] Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis
    Mian, Agrima
    Naqvi, Syed Arsalan Ahmed
    Ayaz, Ahsan
    Husnain, Muhammad
    Aljama, Mohammed A.
    Mohyuddin, Ghulam Rehman
    Koehn, Kelly
    Mohan, Meera
    Bin Riaz, Irbaz
    Chakraborty, Rajshekhar
    LEUKEMIA RESEARCH, 2023, 131
  • [40] Depletion of CD38-positive regulatory T cells by anti-CD38 monoclonal antibodies induces a durable response to SARS-CoV-2 vaccination in patients with plasma cell dyscrasia
    Terao, Toshiki
    Naduka, Takashi
    Ikeda, Daisuke
    Fukumoto, Ami
    Kamura, Yuya
    Kuzume, Ayumi
    Tabata, Rikako
    Tsushima, Takafumi
    Miura, Daisuke
    Narita, Kentaro
    Takeuchi, Masami
    Matsue, Kosei
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (04) : 417 - 421
12345